Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
Total
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated other comprehensive Income (loss)
Accumulated Deficit
Non - controlling Interests
Beginning Balance at Dec. 31, 2020 $ (28,734,073) $ 13 $ 358,499 $ 31,670,954   $ (66,232,439) $ 5,468,900
Share-based compensation from issuance of options and compensation-based warrants 102,000     102,000      
Shares issued upon reverse split to avoid fractional shares     19 (19)      
Conversion of note payable to shares 476,036   15,868 460,168      
Net loss (8,221,174)         (8,221,174)  
Ending Balance at Mar. 31, 2021 (36,377,211) 13 374,386 32,233,103   (74,453,613) 5,468,900
Beginning Balance at Dec. 31, 2020 (28,734,073) 13 358,499 31,670,954   (66,232,439) 5,468,900
Net loss (33,980,426)            
Ending Balance at Sep. 30, 2021 (53,368,415)   400,630 40,974,920   (100,212,865) 5,468,900
Beginning Balance at Mar. 31, 2021 (36,377,211) 13 374,386 32,233,103   (74,453,613) 5,468,900
Share-based compensation from issuance of options and compensation-based warrants 154,244     154,244      
Exercise of stock options 9,344   610 8,734      
Purchase of Agribody Technologies, Inc 5,000,000   8,305 4,991,695      
Conversion of Series B Preferred to Common   $ (13) 11,818 (11,805)      
Conversion of convertible notes 308,889   537 308,352      
Issuance of common stock for cash 3,100,000   4,960 3,095,040      
Net loss (14,078,302)         (14,078,302)  
Ending Balance at Jun. 30, 2021 (41,883,036)   400,616 40,779,363   (88,531,915) 5,468,900
Share-based compensation from issuance of options and compensation-based warrants 194,076     194,076      
Exercise of stock options 1,495   14 1,481      
Net loss (11,680,950)         (11,680,950)  
Ending Balance at Sep. 30, 2021 (53,368,415)   400,630 40,974,920   (100,212,865) 5,468,900
Beginning Balance at Dec. 31, 2021 (60,616,693)   420,134 51,142,220   (117,647,947) 5,468,900
Share-based compensation from issuance of options and compensation-based warrants 312,166     312,166      
Exercise of stock options 77,900   2,105 75,795      
Issuance of warrants 68,394,561     68,394,561      
Issuance of warrants in subsidiary 4,552,911           4,552,911
Deemed contribution in connection with issuance of preferred stock to Senior Lenders 9,942,069     9,942,069      
Accretion of 15.00% Series C preferred shares (2,664,462)     (2,664,462)      
Foreign currency translation adjustment (2,327)       $ (2,327)    
Net loss (17,158,596)         (17,158,596)  
Ending Balance at Mar. 31, 2022 2,837,529   422,239 127,202,349 (2,327) (134,806,543) 10,021,811
Beginning Balance at Dec. 31, 2021 (60,616,693)   420,134 51,142,220   (117,647,947) 5,468,900
Net loss (34,873,814)            
Ending Balance at Sep. 30, 2022 (1,425,346)   423,239 130,067,339 169,817 (152,521,761) 20,436,020
Beginning Balance at Mar. 31, 2022 2,837,529   422,239 127,202,349 (2,327) (134,806,543) 10,021,811
Share-based compensation from issuance of options and compensation-based warrants 495,984     495,984      
Exercise of stock options 48,350   1,000 47,350      
Accretion of 15.00% Series C preferred shares (6,808,574)     (6,808,574)      
Foreign currency translation adjustment 16,618       16,618    
Net loss (2,400,783)         (2,400,783)  
Ending Balance at Jun. 30, 2022 (5,810,876)   423,239 120,937,109 14,291 (137,207,326) 10,021,811
Share-based compensation from issuance of options and compensation-based warrants 737,141     737,141      
Issuance of warrants 14,309,472     14,309,472      
Revaluation of warrants 1,626,918     1,626,918      
Revaluation of warrants in subsidiary 10,414,209           10,414,209
Accretion of 15.00% Series C preferred shares (7,543,301)     (7,543,301)      
Foreign currency translation adjustment 155,526       155,526    
Net loss (15,314,435)         (15,314,435)  
Ending Balance at Sep. 30, 2022 $ (1,425,346)   $ 423,239 $ 130,067,339 $ 169,817 $ (152,521,761) $ 20,436,020